
Sign up to save your podcasts
Or


Pulmonary hypertension clinical trials have almost traditionally focused primarily on Group 1 patients. However, recent interest has been built around non-Group 1 patients or on subgroups of the Group 1 category. This expert roundtable explores some of the issues particular to PH patients not often found in the idiopathic groups often used for clinical trials.
By ReachMD4.3
33 ratings
Pulmonary hypertension clinical trials have almost traditionally focused primarily on Group 1 patients. However, recent interest has been built around non-Group 1 patients or on subgroups of the Group 1 category. This expert roundtable explores some of the issues particular to PH patients not often found in the idiopathic groups often used for clinical trials.